Novo Nordisk A S NVO
NYSE NVO
$38.89 -0.56 (-1.42%)
At close: Nov 19, 2026 · 4:00 PM EST

Novo Nordisk A S (NVO) Operating Income (2012 - 2016)

Updated

Novo Nordisk A S's Operating Income was $1.62 billion in the quarter ended Dec 31, 2016.

Analysis

Novo Nordisk A S (NVO) Operating Income (2012 - 2016) Analysis & Trends

On a trailing twelve-month basis, Novo Nordisk A S's Operating Income was $84.41 billion through Dec 31, 2016; for the year ended Dec 31, 2014, it was $34.49 billion, up 9.5% from the prior year.

  • Operating Income has now increased for five consecutive years, with a five-year compound annual growth rate of 18.2% (years ended Dec 2009 to Dec 2014).
  • In earlier years, Operating Income was $31.49 billion in the year ended Dec 31, 2013 (+6.9%), $29.47 billion in the year ended Dec 31, 2012 (+31.7%), $22.37 billion in the year ended Dec 31, 2011 (+18.4%) and $18.89 billion in the year ended Dec 31, 2010 (+26.5%).
  • The figure for the quarter ended Dec 31, 2016 marks the highest quarterly Operating Income since the quarter ended Dec 31, 2014.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 1.62 Bn
Dec 31, 2014 60.48 Bn
Dec 31, 2012 1.32 Bn
API Access

Novo Nordisk A S Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=NVO&period=max&api_key=YOUR_API_KEY